UNICANCER AcSe Nivolumab
- ORGANE :
- COMITE CGFL : XXMULTIORGANE
- PHASE : XXMULTIORGANE
- DATE : 2017-12-20
Médecin : Dr. GHIRINGHELLI
ARC : Héritier Kitupa Lase [3784] 03 80 73 77 52
Secured access to nivolumab for adult patients with selected rare cancer types